PRCT Q1 2023 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena

PRCTPROCEPT BioRobotics Corporation

$1B

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$24M+71.9% YoY

Gross Profit

$12M51.2% margin

Operating Income

-$28M-116.3% margin

Net Income

-$28M-116.7% margin

EPS (Diluted)

$-0.63

QoQ Revenue Growth

+2.6%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$41M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$284M

Total Liabilities

$111M

Stockholders' Equity

$173M

Cash & Equivalents

$182M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$14M	+71.9%
Gross Profit	$12M	$8M	+62.4%
Operating Income	-$28M	-$16M	-80.7%
Net Income	-$28M	-$17M	-65.7%

Geographic Segments

UNITED STATES

$9M86%

Outside the United States

$1M14%